PAREXEL INTERNATIONAL CORPORATION Toevoegen aan een lijst
Inactief instrument
Onderneming PAREXEL International Corporation
Aandelen
US6994621075
Biotechnologie & Medisch Onderzoek
Managers
| Managers | Titel | Leeftijd | Van |
|---|---|---|---|
Duncan MacDonald
CEO | Chief Executive Officer | 56 | - |
Gregory Rush
DFI | Director of Finance/CFO | 56 | - |
Amy McKee
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-01-19 |
Michael Crowley
ADM | Chief Administrative Officer | - | 01-01-09 |
Jonathan Shough
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-22 |
Peyton Howell
COO | Chief Operating Officer | 56 | 01-05-18 |
| Investor Relations Contact | - | - | |
| Corporate Officer/Principal | - | 01-01-20 |
Besturend
| Besturend | Titel | Leeftijd | Van |
|---|---|---|---|
Sherilyn McCoy
CHM | Chairman | 65 | - |
Duncan MacDonald
CEO | Chief Executive Officer | 56 | - |
May Kin Ho
BRD | Director/Board Member | 71 | 26-08-15 |
Eric Liu
BRD | Director/Board Member | 47 | 01-11-21 |
William Chase
BRD | Director/Board Member | 57 | - |
John Groetelaars
BRD | Director/Board Member | 58 | 23-06-23 |
Michael Bruun
BRD | Director/Board Member | - | 23-06-23 |
Aandelenklasse
| Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
|---|---|---|---|---|---|
| Aandeel A | 1 | 51 115 310 | 50 131 867 ( 98,08 %) | 0 | 98,08 % |
Bedrijfsgegevens
PAREXEL International Corp.
275 Grove Street Suite 101C
02466, Newton
+617 454 9300
http://www.parexel.com
Sector
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +25,69% | 47,9 mld. | |
| +46,90% | 41,42 mld. | |
| -3,46% | 40,7 mld. | |
| -6,20% | 28,92 mld. | |
| +9,17% | 25,55 mld. | |
| -20,42% | 19,27 mld. | |
| +0,17% | 12,15 mld. | |
| +28,07% | 12,14 mld. | |
| -1,24% | 11,99 mld. |
